Medical Therapy of Prostatic Symptoms

PHASE3CompletedINTERVENTIONAL
Enrollment

3,407

Participants

Timeline

Start Date

December 31, 1995

Primary Completion Date

November 30, 2001

Study Completion Date

November 30, 2001

Conditions
Prostatic HyperplasiaProstatic Hypertrophy, Benign
Interventions
DRUG

Doxazosin

DRUG

Finasteride

DRUG

Doxazosin placebo

DRUG

Finasteride placebo

Trial Locations (17)

10010

New York University School of Medicine, New York

10032

Columbia Presbyterian Medical Center, New York

20307

Walter Reed Army Medical Center, Washington D.C.

21201

University of Maryland, Baltimore

30322

Emory University, Atlanta

48202

Henry Ford Health Systems, Detroit

52242

University of Iowa Hospitals Clinics, Iowa City

55905

Mayo Foundation, Rochester

60611

Northwestern University, Chicago

63141

Washington University, St Louis

77005

Baylor College of Medicine, Houston

92093-0694

University of California, La Jolla

80010-0510

Univ of Colorado Health Sciences Center, Aurora

06520

Yale University, New Haven

37232-2765

Vanderbilt University, Nashville

5235-9110

UT Southwestern Medical Center, Dallas

78234-6200

Brooke Army Medical Center, San Antonio

All Listed Sponsors
collaborator

George Washington University

OTHER

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00021814 - Medical Therapy of Prostatic Symptoms | Biotech Hunter | Biotech Hunter